BVD Shield 3This page contains information on BVD Shield 3 for veterinary use.
The information provided typically includes the following:
- BVD Shield 3 Indications
- Warnings and cautions for BVD Shield 3
- Direction and dosage information for BVD Shield 3
BVD Shield 3This treatment applies to the following species:
Bovine Virus Diarrhea Vaccine
For Use In Animals Only
BVD Shield 3 Indications
For use in healthy cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by bovine virus diarrhea (BVD Type 1 and BVD Type 2) viruses. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates.
ADJUVANT: Xtend® SP.
Directions For Use
Shake well before using. Administer 2 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 4-5 weeks. Vaccinate dairy cows at dry-off. Revaccinate annually or as recommended by your veterinarian.
PrecautionsStore out of direct sunlight at 2°-7° C (35°-45° F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2007 Novartis; Registered trademarks of Novartis AG
NAC No.: 11140842
Farm Animal Business
1447 140TH ST., LARCHWOOD, IA, 51241
|Every effort has been made to ensure the accuracy of the BVD Shield 3 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2014 North American Compendiums. Updated: 2014-09-05